Microdosing psychedelics: Demographics, practices, and psychiatric comorbidities.
Adolescent
Adult
Cross-Sectional Studies
Dose-Response Relationship, Drug
Female
Hallucinogens
/ administration & dosage
Humans
Lysergic Acid Diethylamide
/ administration & dosage
Male
Mental Disorders
/ epidemiology
Psilocybin
/ administration & dosage
Substance-Related Disorders
/ epidemiology
Surveys and Questionnaires
Young Adult
LSD
Psychedelics
microdosing
psilocybin
substance use
Journal
Journal of psychopharmacology (Oxford, England)
ISSN: 1461-7285
Titre abrégé: J Psychopharmacol
Pays: United States
ID NLM: 8907828
Informations de publication
Date de publication:
06 2020
06 2020
Historique:
pubmed:
29
2
2020
medline:
9
7
2021
entrez:
29
2
2020
Statut:
ppublish
Résumé
Microdosing psychedelics - the practice of consuming small, sub-hallucinogenic doses of substances such as LSD or psilocybin - is gaining attention in popular media but remains poorly characterized. Contemporary studies of psychedelic microdosing have yet to report the basic psychiatric descriptors of psychedelic microdosers. To examine the practices and demographics of a population of psychedelic microdosers - including their psychiatric diagnoses, prescription medications, and recreational substance use patterns - to develop a foundation on which to conduct future clinical research. Participants ( Of microdosers, most reported using LSD (59.3%; M Well-designed randomized controlled trials are needed to evaluate the safety and tolerability of this practice in clinical populations and to test claims about potential benefits.
Identifiants
pubmed: 32108529
doi: 10.1177/0269881120908004
doi:
Substances chimiques
Hallucinogens
0
Psilocybin
2RV7212BP0
Lysergic Acid Diethylamide
8NA5SWF92O
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM